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Abstract 30 
Background: Dementia is the most common neurological disorder worldwide and is a life-limiting 31 
condition, but very often is not recognised as such. People with dementia, and their carers, have been 32 
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shown to have palliative care needs equal in extent to those of cancer patients. However, many 33 
people with advanced dementia are not routinely being assessed to determine their palliative care 34 
needs, and it is not clear why this is so.  35 
Main Body: An interdisciplinary workshop on “Palliative Care in Neurodegeneration, with a focus on 36 
Dementia”, was held in Cork, Ireland, in May 2016. The key aim of this workshop was to discuss the 37 
evidence base for palliative care for people with dementia, to identify ‘gaps’ for clinical research, and 38 
to make recommendations for interdisciplinary research practice. To lead the discussion throughout 39 
the day a multidisciplinary panel of expert speakers were brought together, including both researchers 40 
and clinicians from across Ireland and the UK. Targeted invitations were sent to attendees ensuring 41 
all key stakeholders were present to contribute to discussions. In total, 49 experts representing 17 42 
different academic and practice settings, attended. 43 
Key topics for discussion were pre-selected based on previously identified research priorities (e.g. 44 
James Lind Alliance) and stakeholder input. Key discussion topics included: i. Advance Care Planning 45 
for people with Dementia; ii. Personhood in End-of-life Dementia care; iii. Topics in the care of 46 
advanced dementia at home. These topics were used as a starting point, and the ethos of the 47 
workshop was that the attendees could stimulate discussion and debate in any relevant area, not just 48 
the key topics, summarised under iv. Other priorities. 49 
Conclusions: The care experienced by people with dementia and their families has the potential to 50 
be improved; palliative care frameworks may have much to offer in this endeavour. However, a solid 51 
evidence base is required to translate palliative care into practice in the context of dementia. This 52 
paper presents suggested research priorities as a starting point to build this evidence base. An 53 
interdisciplinary approach to research and priority setting is essential to develop actionable knowledge 54 
in this area. 55 
Keywords: Dementia; Neurodegenerative diseases; Interdisciplinary research; Research priorities; 56 
Advance Care Planning; Personhood; Care at home. 57 
 58 
Background 59 
Dementia causes impairment of memory, problem-solving and communication, and in advanced 60 
disease, the ability to perform everyday tasks[1]. Dementia is one of the major causes of disability and 61 
dependency among older people and it is not a normal part of ageing. In the United Kingdom and 62 
Wales, dementia is the leading cause of death[2]. Worldwide, 47.5 million people have dementia and 63 
there are 7.7 million new cases every year[3]. There are at least 48,000 people in the Republic of 64 
Ireland living with dementia; given the ageing population, this number is expected to increase to about 65 
150,000 by 2046[4]. While recent population-based research suggests that the prevalence rate of 66 
dementia in older people may actually be declining[5], due partly to improved healthcare, the number 67 
of people affected by dementia directly or indirectly continues to rise as the population ages and the 68 
number at risk rises. 69 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3 
There is a significant need to increase and expand the research base for palliative and end-of-life 70 
care, in recognition of emerging global priorities[6], including moving beyond cancer to examine other 71 
chronic diseases such as dementia[7]. Dementia is a life-limiting condition, but very often is not 72 
recognised as a terminal illness. People with dementia, and their carers, have been shown to have 73 
palliative care needs equal to those of cancer patients[8]. A palliative care approach is also favoured 74 
by informal caregivers[9].  75 
Palliative care can be defined as: “an approach to care that improves the quality-of-life of patients and 76 
their families facing problems associated with life-threatening illness, through the prevention and relief 77 
of suffering by means of early identification and impeccable assessment and treatment of pain and 78 
other problems, physical, psychosocial and spiritual”[10]. This broad definition covers both i) 79 
generalist palliative care (approach which involves all healthcare workers practicing palliative care 80 
principles as a core skill, supplemented by some healthcare workers who are not engaged full time in 81 
palliative care, but have had additional training and experience in palliative care); and ii) Specialist 82 
Palliative Care services whose core activity is the provision of palliative care to individuals with more 83 
complex and demanding care needs[11]. 84 
Recent international reviews have highlighted the importance of palliative care in 85 
neurodegeneration[12-14]. The Irish National Dementia Strategy placed a particular focus on 86 
palliative care[15]. However, it is difficult to enact policy as the evidence base for the value of 87 
palliative care for people with dementia is still lacking and many people with advanced dementia are 88 
still not routinely being provided with palliative care in practice. Providing high quality palliative care 89 
for people with dementia presents unique challenges, for example the person’s inability to verbally 90 
express preferences for their care as the illness progresses, and the fact that the end-of-life phase 91 
may be long and difficult to identify[16]. Research is also hindered by the lack of agreed outcome 92 
measures, and the challenge of adapting existing tools for use with someone with advanced dementia 93 
who is verbally non-communicative[17]. Assessment of symptoms can be further confounded by the 94 
presence of concurrent illnesses. 95 
In recognition of the importance of this challenge, the international research community has called for 96 
more clinically-relevant, collaborative, and strategic approaches to palliative care research[18-22]. 97 
While many disciplines have recognised the importance of research in palliative care for 98 
neurodegeneration individually, a problem is that researchers are tackling the problem from different 99 
perspectives, theoretical frameworks, and using diverse methodologies; these are complementary but 100 
require a platform for discussion, debate and collaboration. Furthermore, this discussion needs to be 101 
interdisciplinary, and include academics, practitioners and service-users, as one discipline alone 102 
cannot manage the complex physical, psychological, social, and ethical problems in palliative care for 103 
people with dementia. It is important that priorities for future research are set so that questions 104 
pertinent to dementia and palliative care in Ireland could be addressed effectively by researchers of 105 
all relevant disciplines, to enable a strong evidence base to be developed. 106 
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Main text 108 
Planning the workshop 109 
A consortium was established, representing two universities and five non-profit organisations for 110 
dementia and palliative care. The goal of the consortium was to plan an interdisciplinary workshop to 111 
explore the theme: “Palliative Care in Neurodegeneration with a focus on Dementia: Addressing 112 
complex questions through interdisciplinary research and reflection.” The aim of the workshop was to 113 
bring experts together from different disciplines to discuss this theme, to enhance cross-discipline 114 
learning, and to identify and discuss research gaps, priorities and methodologies in palliative care in 115 
neurodegeneration. There are other examples of using a similar approach to identify research 116 
priorities in palliative care (e.g. Stevinson, Preston, & Todd[23]; Jones et al.[24]).   117 
The consortium members identified a long-list of key priority areas for the workshop through review of 118 
existing priority setting exercises. Members then conferred within their own organisations (this 119 
included input from a wider stakeholder network of academics and researchers, clinicians, and people 120 
affected by dementia) and a final short-list with particular relevance to the Irish context was agreed by 121 
the consortium. Next, experts in the chosen priorities were identified by the consortium and invited to 122 
the workshop. Five invited speakers presented at the workshop. 123 
The workshop 124 
In total, 49 experts attended the workshop, representing academics, researchers, and clinicians, from 125 
a range of relevant disciplines (see Table 1). All attendees were identified and targeted as leading 126 
experts in Ireland in either palliative care, neurodegeneration, or both, and attendance was on an 127 
invite only basis. There was also substantial Patient and Public Involvement in both the organisation 128 
and attendance at the event, including family carers of people with dementia and representatives from 129 
national voluntary and charitable organisations.  130 
The workshop was highly participatory, and scheduled such that all delegates had ample opportunity 131 
to partake in discussions throughout the day. The workshop included five facilitated discussions. In 132 
these sessions, invited speakers gave a brief introduction to one of the pre-identified key themes, and 133 
then an independent, second expert facilitated the consequent discussion with the floor. A longer 134 
keynote presentation was delivered by a leading international expert. Two workshop consortium 135 
members independently recorded the core discussion points as they arose, and also gathered and 136 
collated anonymous written comments (each attendee received blank comment cards for each 137 
session). The discussion points and the comments were synopsised by an expert in an afternoon 138 
session with further brief discussion to clarify content and fidelity. The workshop closed with a 139 
facilitated question and answer session with a panel of six experts, three of whom had presented 140 
earlier. 141 
Outcomes 142 
The purpose of this paper is to summarise some of the key research priorities and suggestions for 143 
future research in dementia palliative care, based on core discussion points which arose during the 144 
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5 
workshop. We have provided a general overview of a selection of these key topics against a brief 145 
background literature. We conclude with specific priorities for future research which are taken directly 146 
from discussions during the workshop. This paper is not intended as an exact summary of the 147 
proceedings on the day, however video recordings of the workshop presentations are available 148 
online.  149 
 150 
Discussion topics 151 
1. Overview of Research in neurodegenerative disease 152 
There is an imperative for the development of research into the care of people with 153 
neurodegenerative disease, as at present there are no curative treatments, and the aim of care is to 154 
provide the best supportive and palliative care for these patients and their families. There have been 155 
several documents and discussions about the future of this research including the Priority Partnership 156 
Project in 2015, which was based on a wide consultation on the future priorities for research in 157 
palliative care, initiated by Marie Curie and facilitated by the James Lind Alliance[25]. Ten areas were 158 
prioritised, and of these, the following four have particular relevance to neurodegenerative disease: 159 
access to palliative care; Advance Care Planning; determination of patient needs; assessment and 160 
treatment of pain when communication is complex (see Table 2).  161 
The longer list of suggested research topics is also relevant, specifically: the best way of providing 162 
palliative care to people with dementia; swallowing problems at end-of-life; drooling, which often 163 
accompanies reduced swallowing; assessment of distress in dementia; carer support and training for 164 
carers; continuity of care; understanding the person’s needs in neurological disease and dementia. 165 
Within Europe, the Joint Programme - Neurodegenerative Disease Research (JPND) has been 166 
considering the research priorities and suggested the following: needs assessment, the identification 167 
of transitions along the pathway (such as the move to institutional care), and consideration of effective 168 
models across Europe[26].  Suggested priorities include quality improvement and research funding to 169 
establish effective strategies to achieve them. Specific priorities within these two related domains 170 
have been identified (Table 3). These areas may now be considered in greater depth and it is hoped 171 
that there will be opportunities for funding to look at these areas. 172 
A recent Consensus document on neurological palliative care has been produced and endorsed by 173 
the European Academy of Neurology and the European Association for Palliative Care[14]. This 174 
Consensus has suggested areas for development in the palliative care for all patients with chronic 175 
and progressive neurological disease, considering in particular: ensuring palliative care approach 176 
included in overall care, communication and Advance Care Planning, symptom management, 177 
multidisciplinary team approach, family support, carer support, bereavement care, discussion of end-178 
of-life care and the recognition of end-of-life care and the identification and use of triggers for 179 
palliative care[14]. Research into these areas would help to facilitate these developments and provide 180 
the evidence base that is so often missing. A Delphi Study on palliative care for people with dementia, 181 
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produced as a White Paper from the EAPC[27], found that the areas for research that received the 182 
highest importance ratings were person-centred care, communication and shared decision making; 183 
optimal treatment of symptoms and providing comfort, setting care goals and advance planning.    184 
Together, these documents suggest that the palliative care needs of people with neurodegenerative 185 
diseases, including dementia, requires more research and there needs to be a unified approach, 186 
linked to existing evidence, and at all levels – locally, nationally, across Europe, and across the world. 187 
Such an approach should be informed by regional priorities and may be guided using specific 188 
frameworks and models of care.  189 
 190 
2. Frameworks for planning and conducting research in palliative care and dementia 191 
Dementia is a devastating illness which can affect every one of us in some way. Most widely, we all 192 
know someone with dementia and its symptoms and might all aim to achieve prevention in our own 193 
lives; a smaller number of us provide support and care for those so affected (and ourselves may need 194 
support); and an even smaller number attempt to address these needs through research and practice 195 
development.   196 
The life-long journey is fraught with difficulty: those affected by dementia experience pain, loss of 197 
appetite, poor swallow, general fear and agitation, relationship problems and mental illness, 198 
infections, pressure ulcers and communication difficulties. If so affected, we need substantial help 199 
with activities of daily living and we might suffer social stigma and even the side-effects of treatments. 200 
The journey is at once unique to each of us, yet we must navigate it together and make decisions at 201 
all levels about where to place our emphasis.  202 
Two frameworks are offered to guide our thinking. First is the Health Career model devised by 203 
Hodges[28] which can be seen in Figure 1. The model distinguishes four domains: sciences; political; 204 
sociology; and interpersonal, and challenges us to consider the potential to influence health outcomes 205 
from a range of viewpoints. From the mechanistic side, science and politics attempt to deal with cause 206 
and effect, costs and benefits, trade-offs and “hard” evidence to shape services. From the humanistic 207 
side come psychology, ethics, culture and sociology to address fear and stigma of illness, death and 208 
dying; addressing our relationships in support of one another. Hodges recognises the complexity of 209 
disease and, through his model, challenges modern thinking about how we address these challenging 210 
and interrelated symptoms of a complex disease. Interested readers are referred to this blog[29] for 211 
further reading. This model may provide a useful theoretical and conceptual framework for 212 
researching dementia and palliative care. 213 
The second framework is the more familiar schematic timeline, see Figure 2. The palliative care 214 
continuum offers a somewhat more one-dimensional or simpler view of the journey from screening for 215 
disease in an otherwise healthy population, through diagnosis into a zone where elements of curative 216 
and palliative care combine to achieve quality-of-life, right up to (and including) death and (for those 217 
close by) bereavement support. The long course of the illness allows some potential to navigate the 218 
journey, address secondary prevention and consider rehabilitation models in order to achieve as good 219 
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7 
a quality-of-life as possible. There are other models of palliative care involvement, including a varying 220 
involvement, according to need, throughout the disease progression – as shown in Figure 3. This 221 
model is of particular relevance in progressive neurological disease, such as dementia, where there 222 
are times of specific deterioration such as in feeding or breathing, but at other times the disease 223 
progression is slow. 224 
Within the holistic remit of palliative care lie four primary components: the physical, social, spiritual 225 
and psychological. These frameworks aim to inform thinking, and highlight gaps in our knowledge 226 
where multi-professional, inter-disciplinary views, expertise and effort can be brought together to help 227 
make sense of complex issues in dementia. Specific research priorities have been identified (Table 2) 228 
and go some way to highlight the current unanswered questions. Hodges Health Career Model and 229 
the Palliative Care Continuum can help to ensure that the journey ahead is well-travelled. Future 230 
research could usefully explore the intersection of these two models. 231 
 232 
3. Research priorities in Advance Care Planning for people with Dementia 233 
In the United Kingdom and Ireland, various policy documents have called for improvements in care for 234 
people with dementia towards the end-of-life by promoting the use of ‘Advance Care Planning’[30-33]. 235 
In Ireland, pioneering legislation was introduced in 2015 in the form of the Assisted Decision Making 236 
(Capacity) Act[34], which provides the legal guidance to uphold the autonomy and dignity of the 237 
person with dementia, and may be an exemplar for other countries. It has been suggested that 238 
everyone should be encouraged to identify their needs, priorities and preferences for end-of-life 239 
care[30]. This may seem to be a challenge for those with mental capacity, but will be especially 240 
challenging for people with cognitive impairment and language deficits which reduces their ability to 241 
express their preferences. Autonomy in decision making depends upon consciousness of our past 242 
and future thoughts and actions in the same way as we are conscious of our present thoughts and 243 
actions[35]. However, as dementia progresses, in particular, the ability to consider future thoughts[36] 244 
and actions become compromised and this affects the capacity to make decisions[37]. 245 
Proxy decision making. Older people often trust loved ones to make healthcare decisions on their 246 
behalf[38] and want those decisions to be in keeping with their own wishes and preferences[39].  247 
Family carers are assumed to know what these wishes and preferences would have been had the 248 
person with dementia not lost capacity[40] and professionals often rely on family members to predict 249 
and articulate these preferences with assumed accuracy[41]. However, research shows this 250 
assumption to be misplaced[37], with family carers often not able to accurately reflect the preferences 251 
of a person with dementia in the absence of prior discussions or a documented advance care 252 
plan[42]. Proxy decision making can be confounded as such decisions may be impossible to separate 253 
from the family carers’ own views and furthermore, where the family carer has supportive (or other) 254 
care needs of their own. Accordingly, the limits and potential of proxy decision making in the Irish 255 
context, require further clarification and research. 256 
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Future research priorities for Advance Care Planning in Dementia. Overall there is little evidence to 257 
support Advance Care Planning in dementia as a specific intervention. We need to test a feasible and 258 
acceptable Advance Care Planning intervention for families affected by dementia[43] and to test it 259 
over time. However, given the average life span of a person with dementia[44], this presents the 260 
researcher with considerable challenges. Funding for such a study that would recruit people with 261 
dementia from an early stage, when they are more likely to have the capacity to develop an advance 262 
care plan; through to end-of-life, to be able to measure its effectiveness, may render it unfeasible in 263 
respect of normal funding time scales.   264 
These long time scales assume that the only evidence for practice comes from long term prospective 265 
trails. Other forms of ethical decision-making can be informed by professional and personal 266 
experience of patients and family members. However, as noted above, there is scant evidence on the 267 
compatibility of the priorities and wishes of the family carer and the person with dementia, and if these 268 
change over time, converging or diverging, and if it is influenced by the progression of the disease or 269 
by transitions in care. Such evidence as exists suggests their perspectives differ greatly at the 270 
outset[42, 45] but, could an intervention be developed that works systemically with the whole family to 271 
develop a realistic, shared decision making approach? We know that families affected by dementia do 272 
benefit from early and ongoing practical and emotional support[46], but can this be extended to 273 
prepare them for potential changes and aid decision making in the context of the realities of care 274 
towards the end-of-life[47]? To do this, we need to develop a greater understanding of what factors 275 
influence the agreement or divergence of views, or how these issues are handled in skilled practice. 276 
We also lack knowledge as to whether an Advance Care Planning intervention is a viable option for 277 
people in different stages of dementia. Often capacity assessments are not always carried out to 278 
consider specific decisions in respect of end-of-life care preferences so further study is warranted on 279 
how we can ensure people with dementia in the moderate to advanced stages of the illness are 280 
supported to engage in the decision making processes for their end-of-life care. We also need to 281 
establish the stability of these views over the dementia journey. 282 
 283 
4. Research Priorities in Personhood in End-of-life Dementia care  284 
‘Person-centred care,' since its rise in popularity in the 1980’s, has become a catchphrase for good 285 
dementia care.  However, while the phrase is central to policy and education on dementia, many 286 
people with dementia have not experienced improvements in care. The primary proponent of person-287 
centred care in dementia, Tom Kitwood[48], made a very insightful statement in his book, Dementia 288 
Reconsidered: 289 
“It is conceivable that most of the advances that have been made in recent years might be 290 
obliterated, and that the state of affairs in 2010 might be as bad as it was in 1970, except that it 291 
would be varnished by eloquent mission statements, and masked by fine buildings and glossy 292 
brochures” p.133 293 
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If we are to ensure that person-centred care is more than a name-check in a mission statement, it is 294 
essential that we explore the meaning of personhood right along the spectrum of dementia to end-of-295 
life care. Personhood is a standing or status that is bestowed on one human being, by others, in the 296 
context of relationship and social being. It implies recognition, respect and trust. It is a commitment on 297 
behalf of one to recognize the unique contribution of all human beings: primarily the person living with 298 
dementia, but also the family carer, the volunteer, the unqualified assistant and healthcare 299 
professionals[48].   300 
For the research community there are many hurdles to surpass before we can realize this challenge. 301 
It can be difficult for ethics committees to accept the necessity of involving vulnerable people in 302 
research as co-researchers[49], a position which has led to a silence of the voice of people with 303 
dementia for too long. This position serves to reinforce the idea that people with dementia may not 304 
have a worthwhile contribution to make or that they are too vulnerable to require anything of them. Of 305 
course these concerns are to be taken seriously but the larger danger may well be the resulting lack 306 
of voice.   307 
Assuming ethical permissions, there is an emerging but neophyte literature on the methods required 308 
to elicit useful data when people with dementia are taking part in research studies. As people with 309 
dementia are not in any way homogenous, the skills required are hugely varied not just from person to 310 
person, but from day to day and week to week, depending on context and many other factors we are 311 
yet to fully understand.   312 
One example that explores the uniqueness of human response at the later stages of dementia is the 313 
AwareCare study[50]. They proposed that if care staff can be trained to identify signs of awareness 314 
this should support greater responsiveness and facilitate the expression of awareness. They found 315 
seven spontaneously occurring stimuli (e.g. someone nearby) and three introduced stimuli (e.g. call 316 
by name), with 14 response categories sub-divided into movement (eyes, face, head, arm and body) 317 
and sounds. Importantly, use of the tool led to relatives rating improvements in wellbeing and quality-318 
of-life of the person with dementia. 319 
There is a great need for creativity in research to generate knowledge that supports the translation of 320 
person-centred care not just as a watch-word for good care but as an illumination of how that may be 321 
practiced.   322 
 323 
5. Research topics in the care of advanced dementia at home and in 24-hour care  324 
In Ireland and the United Kingdom, acute hospital care is under huge pressure with large overspends 325 
on unplanned emergency admissions. Older people occupy increasing numbers of acute care beds, 326 
and most people with dementia present to the Emergency Department or and/or acute medical 327 
assessment unit in the last six months of life[51]. Good care at home may help avoid this, and the 328 
associated costs, as well as supporting good outcomes. Advanced dementia care at home has been 329 
piloted by Treloar et al.[52] and further described by the Kings Fund[53]. Data from studies have 330 
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10 
indicated substantial savings as a result of advanced dementia care at home. Sampson et at[51] 331 
found that care costs over the six months before death were higher in care homes or continuing care 332 
(£37,029) than for those living at home (£19,854). The Housing 21 Dementia Voice project in 333 
Westminster[54] reported that “over a 24-month period, it is estimated that the Dementia Voice Nurse 334 
service wholly or partly contributed to savings of £314,440 through the avoidance of hospital, nursing 335 
and residential home admission and the use of ambulance services”. Results from the Hope for Home 336 
study[52] indicated that total savings of home care compared with nursing home care for 14 patients 337 
was approximately £700K and that 57% of participants died in their own home. An audit of 23 patients 338 
cared for by the Greenwich Advanced Dementia service in 2009 found that, in total, these patients 339 
were cared for at home for 6,205 days or approximately 886 weeks. Savings to local health and social 340 
care commissioners from these patients were estimated at between £200 and £350 per week, saving 341 
upwards of £177,200 to £310,100 for these patients. These savings are notional as the numbers of 342 
people using the service are too small to enable commissioners to release money from closing 343 
beds[53]. Using similar assumptions, the Greenwich Advanced Dementia Project estimates that it 344 
saved over £2 million caring for 100 patients. However, this data is “soft” and formal economic 345 
analysis of such services is very difficult. There is a real need for better quality economic data to 346 
complement patient-focused outcome data.   347 
 348 
Despite the possible economic savings, supporting the care of people with advanced dementia at 349 
home is poorly understood and rarely prioritised by statutory services. Central to enabling care at 350 
home for a person with advanced dementia, is carer resilience. The START (STrAtegies for 351 
RelaTives) trial implemented a manualised intervention programme and aimed to improve carer 352 
coping strategies. The trial demonstrated reduced depression and anxiety in family carers of people 353 
with Dementia at 8 months and 2 years post intervention and also suggested savings[55]. 354 
 355 
Palliative care of a person with dementia at home also depends upon skilled healthcare, and 356 
expertise that enables competent professional advice to support carers in what they are doing. The 357 
principles of care of the Oxleas Advanced Dementia Service are good guiding principles, these are 358 
outlined in Table 4.  359 
 360 
6. Other research priorities 361 
In addition to the aforementioned themes, there were a number of recurring issues raised during 362 
discussion sessions during the workshop; these are discussed briefly in the following paragraphs and 363 
summarised in Table 2. 364 
i. Research design, including the choice of appropriate methodologies, can be challenging in palliative 365 
care and dementia. By nature, large scale trials and longitudinal studies will be difficult and may not 366 
always be feasible. It is also critical to identify the best ways to capture the potential benefit of 367 
Advance Care Planning in palliative care and dementia. A research priority must be the identification 368 
and validation of appropriate outcome measures to explore benefit (if any) of palliative care. It was 369 
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agreed that this still-emerging research area would benefit from smaller scale studies in the short-370 
term, including: quality improvement studies, smaller pilot studies, and observational studies to better 371 
inform interventions in future trials. This aligns with the recommendations of the Medical Research 372 
Council (MRC) framework for the evaluation of complex health interventions[56]. The MRC framework 373 
was developed in light of the limitations of randomised control trials, mainly limited contextual data, 374 
and outlines the steps for process evaluation, i.e. methods to assess fidelity and quality of 375 
implementation, clarify causal mechanisms and identify contextual factors associated with variation in 376 
outcome.  377 
ii. There is a research gap concerning our understanding of the lived experience of the person with 378 
advanced dementia. In this context Public and Patient Involvement (PPI) in research is critical. 379 
However, it is important that PPI is not incorporated as a token exercise, but rather researchers must 380 
aim to achieve useful and actionable outcomes and goals through patient and public participation in 381 
research. It is essential that people with advanced dementia are also included in research. For this to 382 
happen, innovative research methods must be utilised, as many people living with dementia at this 383 
advanced stage will be verbally non-communicative.  384 
iii. Palliative care for dementia, and neurodegeneration has been supported in policy for some years, 385 
however in practice this is a new area for many healthcare staff and there is a need for it to be 386 
actioned in routine practice across disciplines. Therefore, research needs to investigate the optimal 387 
methods to change healthcare workers’ behaviours concerning palliative care for their patients with 388 
dementia. There are various recognised methods, some may be ethically questionable, such as 389 
financially incentivising nurses and other healthcare staff. A better course may be to look at 390 
implementing education programmes, and critically assess the sustainability of change following an 391 
education intervention. These programmes might include methods to help staff to get to know the 392 
person with dementia better, to improve quality of care, etc. Overall, research is needed to investigate 393 
which methods are the best way to sustain positive changes in staff behaviours for the long-term. 394 
iv. Another priority is to develop useful and transferrable models of best care. In developing these, the 395 
key questions are: how to best integrate palliative care and dementia care, and identification of the 396 
facilitators and barriers to such integration; how to integrate care not only across disciplines but also 397 
sectors, including acute, community, residential care; and determining the existing access to 398 
specialist services for people with dementia. A small number of existing clinics have pioneered 399 
models of palliative care for dementia or other neurodegenerative illnesses, and these can serve as 400 
exemplary models of excellence. Learning from existing models that are performing well may be done 401 
through a cross-case analysis to identify the core principles and practices that are happening at each 402 
site, mapping across the models to look at the commonalities and differences and build a taxonomy of 403 
that model. Thus (as above) more conceptual research is needed, in addition to large scale trials and 404 
studies. In any model, cost effectiveness is critical, but it is impossible to accurately measure cost 405 
effectiveness unless the model of care is properly described.  The development of these frameworks 406 
would be highly useful as they could be subsequently replicated in multiple sites. 407 
 408 
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v. Other topics that arose at this workshop included “chemical restraint” and the issue of inappropriate 409 
antipsychotic prescribing; dying at home, particularly transferring people at end-of-life from an acute 410 
hospital setting to die at home, and the effect of this on quality of death and dying; palliative care in 411 
primary care; improving staff and carers’ recognition of need (i.e. if a need is not recognised by 412 
others, it will never be addressed); the potential use of technology to assist in assessment where 413 
communication is limited, and in supporting care provision; exploration of potential conflicts in the 414 
views of the person with dementia, their family and healthcare workers towards end-of-life. The 415 
considered application of frameworks (such as Hodges Model) may provide a useful mapping 416 
framework for priority setting and enable other areas requiring attention to be highlighted. 417 
 418 
Conclusions 419 
The care experienced by people with dementia and their families has the potential to be improved 420 
through using palliative care frameworks. However, a solid evidence base is required to inform how to 421 
achieve such improvements. As a relatively new field, there are significant methodological and 422 
content areas where research is needed. An expert consortium has highlighted priorities for future 423 
research (Table 2). Integrated care may improve outcomes, notably quality-of-life, for people with 424 
dementia[57], hence an interdisciplinary approach to research and priority setting is essential to 425 
further actionable knowledge in this area. It is also imperative that there needs to be a unified 426 
approach at all levels – nationally, across Europe, and across the world. 427 
This paper summarises key topics in dementia palliative care, based in part on a consensus 428 
workshop, and the research priorities discussed here were not identified through systematic or 429 
empirical research studies. Further, the priorities were discussed primarily with relevance to the Irish 430 
context, and while most are common to international dementia research, there may be country-431 
specific priorities owing to unique cultures, different healthcare systems, different state of current 432 
research, etc. However notable strengths of this paper, and the workshop which stimulated its 433 
development, are that the consensus group included targeted national and international experts from 434 
a variety of academic and professional disciplines, and had substantial Patient and Public 435 
Involvement. A literature review was also performed to place the research priorities discussed into 436 
context of international research literature. 437 
We have highlighted some of the research priorities for palliative care and neurodegeneration, as 438 
discussed by a consortium of multidisciplinary experts. We have also suggested two models or 439 
frameworks that may be useful in mapping out topics to guide research in palliative care for people 440 
with dementia and continue to prompt further questions. 441 
 442 
Declarations 443 
Ethics  444 
Not applicable 445 
 446 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
13 
Consent for publication 447 
Not applicable 448 
 449 
Availability of data and materials 450 
Not applicable 451 
 452 
Competing interests 453 
The authors declare that they have no competing interests. 454 
 455 
Authors' contributions 456 
Authors STF, CF, KHD, KI, WGK, AT, DO, ST drafted the original manuscript. CF, KHD, KI, WGK, 457 
AT, DO, SG, ST suggested / made revisions to the manuscript, which were collated by STF. STF, CF, 458 
KHD, KI, WGK, AT, DO, SG, ST approved the final draft of the manuscript. 459 
 460 
Acknowledgements 461 
The authors would like to thank all of the workshop participants who engaged in the discussions 462 
summarised here.  463 
 464 
Funding 465 
This research was supported by a grant from the Irish Research Council. The purpose of the ‘Creative 466 
Connections’ grant award is to fund workshops to cultivate interdisciplinary research in Ireland 467 
focussing on key national and international research priorities. The Council had no significant role in 468 
the design of the workshop or in writing the manuscript. 469 
 470 
 471 
Abbreviations 472 
EAPC – European Association of Palliative Care 473 
JPND - Joint Programme - Neurodegenerative Disease Research 474 
MRC - Medical Research Council 475 
PPI – Patient and Public Involvement 476 
 477 
References 478 
1. National Institute for Health and Care Excellence: Dementia: supporting people with 479 
dementia and their carers in health and social care [CG42]. In. NICE; November 2006 [Last 480 
updated: April 2014]. 481 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
14 
2. Office for National Statistics: Deaths registered in England and Wales (Series DR): 2015. In.; 482 
November 2016. 483 
3. World Health Organisation: Dementia fact sheet. In.: WHO; April 2016. 484 
4. Pierce M, Cahill S, O’Shea E: Prevalence and Projections of Dementia in Ireland, 2011–2046. 485 
Dublin, Ireland: Trinity College Dublin 2014. 486 
5. Langa KM, Larson EB, Crimmins EM, et al.: A comparison of the prevalence of dementia in 487 
the united states in 2000 and 2012. JAMA Internal Medicine 2017, 177(1):51-58. 488 
6. Abernethy AP, Hanson LC, Main DS, Kutner JS: Palliative care clinical research networks, a 489 
requirement for evidence-based palliative care: time for coordinated action. Journal of 490 
palliative medicine 2007, 10(4):845-850. 491 
7. Higginson IJ: End-of-life care: lessons from other nations. Journal of Palliative Medicine 492 
2005, 8(supplement 1):s-161-s-173. 493 
8. Bayer A: Death with dementia: the need for better care. Age and Ageing 2006, 35:101-102. 494 
9. Hughes JC, Robinson L, Volicer L: Specialist palliative care in dementia. BMJ 2005, 495 
330(7482):57-58. 496 
10. WHO definition of palliative care [http://www.who.int/cancer/palliative/definition/en/ ] 497 
11. Dept of Health and Children: Report of the National Advisory Committee on Palliative Care. 498 
. In. Dublin, Ireland; 2001. 499 
12. Boersma I, Miyasaki J, Kutner J, Kluger B: Palliative care and neurology Time for a paradigm 500 
shift. Neurology 2014, 83:561-567. 501 
13. Borasio GD: The role of palliative care in patients with neurological diseases. . Nature 502 
reviews Neurology 2013, 9:292-295. 503 
14. Oliver DJ, Borasio G, Caraceni A, Visser M, Grisold W, Lorenzl S, Veronese S, Voltz R: A 504 
consensus review on the development of palliative care for patients with chronic and 505 
progressive neurological disease. European journal of neurology 2016, 23(1):30-38. 506 
15. Department of Health: The Irish National Dementia Strategy. In. Dublin, Ireland. ; 2014. 507 
16. Hayden C, Parke M, Lynch M, Kelly S: Planning for the Future Project: initiating ‘end of 508 
life’discussions for people with dementia. 2013. 509 
17. Sampson E, Ritchie C, Lai R, Raven P, Blanchard M: A systematic review of the scientific 510 
evidence for the efficacy of a palliative care approach in advanced dementia. International 511 
Psychogeriatrics 2005, 17(01):31-40. 512 
18. Bennett MI, Davies EA, Higginson IJ: Review: delivering research in end-of-life care: 513 
problems, pitfalls and future priorities. Palliative Medicine 2010, 24:456-461. 514 
19. Daveson BA, Harding R, Derycke N, Berghe PV, Edwards S, Higginson IJ: The PRISMA 515 
Symposium 4: how should Europe progress end-of-life and palliative clinical care research? 516 
Recommendations from the proceedings. Journal of pain and symptom management 2011, 517 
42(4):511-516. 518 
20. Kaasa S, Radbruch L: Palliative care research–priorities and the way forward. European 519 
Journal of Cancer 2008, 44(8):1175-1179. 520 
21. Murray S, Barclay S, Bennett MI, Kendall M, Amir Z, Lloyd-Williams M: Editorial: Palliative 521 
care research in the community: it is time to progress this emerging field. Palliative 522 
medicine 2008, 22(5):609-611. 523 
22. Sigurdardottir KR, Haugen DF, van der Rijt CC, Sjøgren P, Harding R, Higginson IJ, Kaasa S: 524 
Clinical priorities, barriers and solutions in end-of-life cancer care research across Europe. 525 
Report from a workshop. European Journal of Cancer 2010, 46(10):1815-1822. 526 
23. Stevinson C, Preston N, Todd C: Defining priorities in prognostication research: results of a 527 
consensus workshop. Palliative medicine 2010, 24(5):462-468. 528 
24. Jones L, Candy B, Davis S, Elliott M, Gola A, Harrington J, Kupeli N, Lord K, Moore K, Scott S: 529 
Development of a model for integrated care at the end of life in advanced dementia: A 530 
whole systems UK-wide approach. Palliative medicine 2016, 30(3):279-295. 531 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
15 
25. Palliative and end-of-life care Priority Setting Partnership 532 
[https://www.mariecurie.org.uk/globalassets/media/documents/research/PeolcPSP_ExecSu533 
mmary_English.pdf] 534 
26. Palliative and end-of-life care research in neurodegenerative disease. Report of the JPND 535 
Action Group. [http://www.neurodegenerationresearch.eu/initiatives/jpnd-alignment-536 
actions/palliative-care/ ] 537 
27. van der Steen JT, Radbruch L, Hertogh CM, de Boer ME, Hughes JC, Larkin P, Francke AL, 538 
Jünger S, Gove D, Firth P: White paper defining optimal palliative care in older people with 539 
dementia: a Delphi study and recommendations from the European Association for 540 
Palliative Care. Palliative medicine 2013:0269216313493685. 541 
28. Hodges BE: The Health Career Model. In: Nursing Practice and Health Care. 1st edn. Edited 542 
by Hinchcliffe SM. London: Edward Arnold; 1989. 543 
29. Jones P: Hodges' Model: Welcome to the QUAD. In., vol. 2016; 2016. 544 
30. Department of Health: End-of-life Care Strategy. Promoting high quality care for adults at 545 
the end of their life. In. England. ; July 2008. 546 
31. Department of Health: Living Well with Dementia: A National Dementia Strategy. In. 547 
England. ; 2009. 548 
32. Department of Health: Prime Ministers Challenge on Dementia: Delivering major 549 
improvements in dementia care and research by 2015. In. England. ; May 2013. 550 
33. The Irish Hospice Foundation: Dementia Guidance Document 2: Advance care planning and 551 
advance healthcare directives with a person with dementia. In. Dublin; 2016. 552 
34. Government of Ireland: ASSISTED DECISION-MAKING (CAPACITY) ACT 2015. In., vol. 553 
Number 64 of 2015,; 2015. 554 
35. Jolley N: Locke: His philosophical thought. . Oxford: Oxford University Press; 1999. 555 
36. Harrison Dening K, Jones L, Sampson EL: Preferences for end-of-life care: a nominal group 556 
study of people with dementia and their family carers. Palliative Medicine 2013, 27(5):409-557 
417. 558 
37. Fratiglioni L, Qiu C: Epidemiology of dementia. In: Oxford Textbook of Old Age Psychiatry. 559 
edn. Edited by Dening T, Thomas A. Oxford: Oxford University Press; 2013: 389-414. 560 
38. High DM: Surrogate decision making. Who will make decisions for me when I can't? Clinics 561 
in geriatric medicine 1994, 10(3):445-462. 562 
39. Whitlatch CJ, Piiparinen R, Feinberg LF: How well do family caregivers know their relatives' 563 
care values and preferences? Dementia 2009, 8(2):223-243. 564 
40. Wendler D, Rid A: Systematic review: the effect on surrogates of making treatment 565 
decisions for others. Annals of Internal Medicine 2011, 154(5):336-346. 566 
41. Emanuel EJ, Emanuel LL: Proxy decision making for incompetent patients: an ethical and 567 
empirical analysis. Jama 1992, 267(15):2067-2071. 568 
42. Dening KH, King M, Jones L, Vickestaff V, Sampson EL: Advance Care Planning in Dementia: 569 
Do Family Carers Know the Treatment Preferences of People with Early Dementia? PLoS 570 
One 2016, 11(7):e0159056. 571 
43. Dening KH, Jones L, Sampson EL: Advance care planning for people with dementia: a 572 
review. International Psychogeriatrics 2011, 23(10):1535-1551. 573 
44. Xie J, Brayne C, Matthews FE: Survival times in people with dementia: analysis from 574 
population based cohort study with 14 year follow-up. bmj 2008, 336(7638):258-262. 575 
45. Dening KH, Jones L, Sampson EL: Preferences for end-of-life care: a nominal group study of 576 
people with dementia and their family carers. Palliative Medicine 2013, 27(5):409-417. 577 
46. Brodaty H, Donkin M: Family Caregivers of people with dementia. Dialogues in Clinical 578 
Neuroscience 2009, 11:217-228. 579 
47. Harrison-Dening K, Wharrad J: Admiral nursing: responding to the call for better end of life 580 
care for people with dementia. Signpost: Journal of Dementia and Mental Health Care of 581 
Older People 2010, 14(3):27-31. 582 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
16 
48. Kitwood TM: Dementia reconsidered: The person comes first.: Open University Press.; 583 
1997. 584 
49. Dewing J, Chalfont G, Cotter A, Fear T, Brown-Wilson C, Crowhurst K, Torry B, Leyshon S, 585 
Wilkinson H, Stanley D: Understanding care homes: a research and development 586 
perspective: Jessica Kingsley Publishers; 2008. 587 
50. Clare L, Whitaker R, Quinn C, Jelley H, Hoare Z, Woods B, Downs M, Wilson B: AwareCare: 588 
development and validation of an observational measure of awareness in people with 589 
severe dementia. Neuropsychological rehabilitation 2012, 22(1):113-133. 590 
51. Sampson E, Mandal U, Holman A, Greenish W, Dening KH, Jones L: Improving end of life 591 
care for people with dementia: a rapid participatory appraisal. BMJ supportive & palliative 592 
care 2012:bmjspcare-2011-000177. 593 
52. Treloar A, Crugel M, Adamis D: Palliative and end of life care of dementia at home is 594 
feasible and rewarding Results from theHope for Home'study. Dementia 2009, 8(3):335-595 
347. 596 
53. Sonola L, Thiel V, Goodwin N, Kodner D: The Kings Fund-  Oxleas Advanced Dementia 597 
Service Supporting carers and building resilience. In.; 2013. 598 
54. Research and Evaluation Team: The Dementia Voice Nurse Service Pilot. Overview of 599 
Findings and Learning from the Evaluation of the Two Year Pilot Programme December 600 
2008 – December 2010. In.; March 2012. 601 
55. Livingston G, Barber J, Rapaport P, Knapp M, Griffin M, Romeo R, King D, Livingston D, Lewis-602 
Holmes E, Mummery C: START (STrAtegies for RelaTives) study: a pragmatic randomised 603 
controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-604 
based coping strategy programme in promoting the mental health of carers of people with 605 
dementia. Health Technology Assessment 2014, 18(61):1-242. 606 
56. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L, O’Cathain A, Tinati 607 
T, Wight D: Process evaluation of complex interventions: Medical Research Council 608 
guidance. bmj 2015, 350:h1258. 609 
57. Lloyd-Williams M, Abba K, Crowther J: Supportive and palliative care for patients with 610 
chronic mental illness including dementia. Current opinion in supportive and palliative care 611 
2014, 8(3):303-307. 612 
 613 
Figure Legends 614 
Figure 1. Showing the four quadrants of Hodges’ Health Career Model (1989) that provide a unique 615 
systematic way to think about research to inform holistic care. 616 
 617 
Figure 2. Showing the Palliative Care Continuum as one-dimensional journey from screening and 618 
diagnosis to end-of-life care.  Evidence is required to inform practice in all segments (coloured).  619 
 620 
Figure 3. The model of dynamic involvement of palliative services based on trigger points (adapted 621 
from NHS England, End of life in long term neurological conditions: A framework for Implementation, 622 
pg.11).  623 
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Table 1. Details of professional backgrounds of workshop delegates.  
Discipline  n 
Nursing 11 
Consultant Physician 8 
Palliative Medicine 4 
Geriatrician 2 
Neurologist 1 
Old Age Psychiatrist 1 
Psychology 7 
Voluntary Sector 7 
Medical Researchers 4 
Law 3 
Family Carers 2 
Pharmacy 1 
General Practitioner 1 
Neuroscience 1 
Microsystems 1 
Physical Sciences 1 
ICT For Healthcare 1 
Speech And Language Therapist 1 
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Table 2. Selection of research priorities set through the James Lind Alliance and revised for Ireland 
by All Ireland Institute of Hospice and Palliative Care (2015) 
Priority research questions identified by James Lind Alliance and All Ireland Institute of Hospice 
and Palliative Care (2015) 
How can access to palliative care services be improved for everyone regardless of where they are 
in the UK? James Lind Alliance #2 
What are the benefits of Advance Care Planning and other approaches to listening to and 
incorporating patients’ preferences? Who should implement this and when? James Lind Alliance 
#3 
What are the best ways to begin and deliver palliative care for patients with non-cancer diseases 
(such as COPD, heart failure, MND, AIDS, multiple sclerosis, Crohn’s disease and stroke)? James 
Lind Alliance #6 / AIIHPC #9 
What are the best ways to assess and treat pain and discomfort in people at the end of life with 
communication and/or cognitive difficulties, perhaps due to motor neurone disease (MND), 
dementia, Parkinson’s disease, brain tumour (including glioblastoma) or head and neck cancer, for 
example? James Lind Alliance #10 
 
Priority research questions identified in May 2016 workshop 
What are the limits and potential of proxy, i.e. family carers, decision making? 
How to best to include people with dementia in research studies, to achieve useful and actionable 
outcomes? 
What is the economic benefit, if any, of care at home services for dementia, and other 
neurodegenerative disease? 
What are the factors that contribute to and build carer resilience in advanced dementia care? 
How can assessment and support through video technology be utilised? 
What are the most appropriate outcome measures to explore benefit (if any) of palliative care? 
These need to be validated in dementia, Parkinson’s disease, motor neuron disease, etc. 
What are the optimal methods to effect change in staff behaviours concerning palliative care for 
their patients with dementia? 
What is the optimal transferrable model of dementia palliative care? 
What is the incidence of, and how can we limit, chemical restraint through inappropriate 
antipsychotic prescribing in advanced dementia? 
What is the effect on quality of death and dying, of being transferred from an acute hospital to die 
at home? 
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How can recognition of need be improved among primary care and other healthcare workers of 
palliative care needs in their patients with dementia, and other neurodegenerative disease? 
 
 
 
Table 3. JPND Palliative and End-Of-Life Care Research in Neurodegenerative Diseases Suggested 
Priorities. 
The following areas are suggested priorities in two related domains: 
 
Improvement of Quality 
1. Support for transnational networking, aiming for multi-professional engagement in 
palliative care research across EU 
2. Co-ordination of best practices across EU member states 
 Working groups looking at developing evidence  
a. Advance care planning 
b. Cognitive impairment and challenges 
c. Effectiveness of education 
d. Primary care involvement in planning for palliative care 
e. Engagement with voluntary groups  
Research Funding 
3. Collaborative research, especially enhancing and using existing population and 
disease based longitudinal cohort studies 
 Looking at triggers / transitions leading to changes in care 
4. Support of research into identification of best practices for needs assessment 
 Multi-method 
 Interdisciplinary 
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Table 4. Principles of care of the Oxleas Advanced Dementia Service. 
 
A core belief of the Oxleas Advanced Dementia Service is that anyone cared for at home with 
advanced dementia deserves care co-ordination and on-going support. The service combines 
mental and physical health expertise, to look competently after patients with advanced dementia 
living at home and to: 
 Comprehensively assess and plan ahead;  
 Co-ordinate care;  
 Respond quickly when needs are changing;  
 Establish a palliative care framework with a focus on maximising quality-of-life, helping to 
avoid or shorten unnecessary and traumatic hospital admissions, treatments and 
investigations, and replace them with home care whenever possible;  
 Offer excellent care towards the end-of-life;  
 Relieve the carer from having to navigate alone within a complex care system while 
grieving. 
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